VJHemOnc is committed to improving our service to you

ERIC 2020 | CLL cell treatment resistance and microenvironmental interactions

VJHemOnc is committed to improving our service to you

Dimitar Efremov

Dimitar Efremov, MD, PhD, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy, discusses how treatment resistance in chronic lymphocytic leukemia (CLL) is mediated by interactions with the cell’s microenvironment. Interaction with B-cell receptors, toll-like receptors, T-cells and macrophages are important in activating signaling pathways for primary proteins. Using cas9, we can understand how selective genetic lesions impact leukemia development, progression and resistance. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter